AKAR, S. Et Al. 2021. GO-BEYOND: a real-world study of persistence of golimumab in patients with axial spondyloarthritis and rheumatoid arthritis in Turkey. IMMUNOTHERAPY , vol.13 , 841-850.

AKAR, S., KALYONCU, U., DALKILIÇ, H. E., EMMUNGİL, H., Aziz, A., Esen, Y., ... Koc, T.(2021). GO-BEYOND: a real-world study of persistence of golimumab in patients with axial spondyloarthritis and rheumatoid arthritis in Turkey. IMMUNOTHERAPY , vol.13, 841-850.

AKAR, SERVET Et Al. "GO-BEYOND: a real-world study of persistence of golimumab in patients with axial spondyloarthritis and rheumatoid arthritis in Turkey," IMMUNOTHERAPY , vol.13, 841-850, 2021

AKAR, SERVET Et Al. "GO-BEYOND: a real-world study of persistence of golimumab in patients with axial spondyloarthritis and rheumatoid arthritis in Turkey." IMMUNOTHERAPY , vol.13, pp.841-850, 2021

AKAR, S. Et Al. (2021) . "GO-BEYOND: a real-world study of persistence of golimumab in patients with axial spondyloarthritis and rheumatoid arthritis in Turkey." IMMUNOTHERAPY , vol.13, pp.841-850.

@article{article, author={SERVET AKAR Et Al. }, title={GO-BEYOND: a real-world study of persistence of golimumab in patients with axial spondyloarthritis and rheumatoid arthritis in Turkey}, journal={IMMUNOTHERAPY}, year=2021, pages={841-850} }